Fierce BD&L Summit for Life Sciences 2023

Eka is a Senior Director of Early Innovation Partnering at Johnson and Johnson. In this role Eka is responsible for identification, diligence and strategic transactions for data science opportunities across therapeutic areas from discovery through commercial execution. Eka joined... Read More →

Ms. Stevens is currently the Head of Business Partnering at AbCellera Biologics Inc., as well as a Director for Aequus Pharmaceuticals and the LifesciencesBC organization. Ms Stevens was previously the Chief Operating Officer of Aequus Pharmaceuticals, a specialty pharmaceutical company... Read More →

Michelle Chen is the Chief Business Officer of Insilico Medicine, a leader in the AI-powered drug discovery and development company.She is responsible for company’s strategies, business and corporate development, revenue growth and US operations. As a biotech executive, Michelle... Read More →

Scott Saywell is the Chief Business Officer at Herophilus, a San Francisco-based neurotherapeutics company focused on curing brain diseases with its proprietary technology platform based on in vitro human tissue models.  Scott has over twenty-five years of experience in the biotech... Read More →

Jeff Landau is currently SVP, Chief Business Officer and Head of Strategy at CytomX Therapeutics (www.cytomx.com) where he leads BD&L, Corporate Strategy, Alliance and Program Management and New Product Planning and has recently closed platform deals with Regeneron and Moderna. Mr. Landau has over 20 years of biopharmaceutical experience in corporate development, corporate strategy, sales and new... Read More →